Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program

International Journal of Tuberculosis and Lung Disease

Volumn 1, Issue 5, 1997, Pages 397-404

  Salomon, N ^a   Perlman, D C ^a   Rubenstein, A ^a   Mandelman, D ^a   McKinley, F W ^a   Yancovitz, S R ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Adherence; Directly observed therapy; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADDICTION; ADULT; AMBULATORY CARE; ARTICLE; CONFIDENCE INTERVAL; FEMALE; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RISK; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; TUBERCULOSIS; UNITED STATES;

ADULT; AMBULATORY CARE; ANTITUBERCULAR AGENTS; CONFIDENCE INTERVALS; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW YORK CITY; ODDS RATIO; PATIENT COMPLIANCE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS; TUBERCULOSIS;

EID: 0031240808     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Raviglione M C, Snider D E, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
2. Tuberculosis in New York City, 1992: information summary. New York: New York City Department of Health, 1993.
3. Bureau of tuberculosis control: information summary. New York: New York City Department of Health, 1995.
4. Frieden T R, Fujiwara P I, Washko R M, Hamburg M A. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333: 229-233.
5. Iseman D I, Cohn D L, Sbarbaro J A. Directly observed therapy for tuberculosis - We can't afford not to try it. N Engl J Med 1993; 328: 576-578.
6. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Am Rev Respir Dis 1991; 144: 745-749.
7. Miller B. Health-care expenditures for TB in the US. Arch Intern Med 1995; 155: 1595-1600.
8. Rosenblum L S, Castro K G, Dooley S, Morgan M. Effect of HEV infection and tuberculosis on hospitalizations and cost of care for young adults in the United States, 1985 to 1990. Ann Intern Med 1994; 121: 786-792.
9. Schluger N, Ciotoli C, Cohen D, Johnson H, Rom W N. Comprehensive tuberculosis control for patients at high risk of noncompliance. Am J Respir Crit Care Med 1995; 151: 1486-1490.
10. El-Sadr W, Medard F, Barthaud V. Directly observed therapy for tuberculosis: the Harlem Hospital experience, 1993. Am J Public Health 1996; 86: 1146-1149.
11. Bureau of tuberculosis control: information summary. New York: New York City Department of Health, 1994.
12. Kelly-Rossini L, Perlman D C, Mason D J. The experience of respiratory isolation for HIV-infected persons with tuberculosis. J Assoc Nurses AIDS Care 1996; 7: 29-36.
13. Perlman D C, Salomon N, Perkins M P, Yancovitz S R, Paone D, Des Jarlais D C. Tuberculosis in drug users. Clin Infect Dis 1995; 21: 1253-1264.
14. Salomon N, Perlman D C, Friedmann P, Buchstein S, Kreiswirth B N, Mildvan D. Predictors and outcome of multidrug-resistam tuberculosis. Clin Infect Dis 1995; 21: 1245-1252.
15. Tuberculosis treatment: City Health Information. New York: New York City Department of Health, 1992.
16. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.
17. Centers for Disease Control and Prevention. 1993 revised classification for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1992; 41 (RR-17): 1-19.
18. Coombs D L, O'Brien R, Geiter L J. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity, and acceptability. Ann Intern Med 1990; 112: 397-406.
19. Sbarbaro J A, Catlin B J, Iseman M. Long-term effectiveness of intermittent therapy for tuberculosis: Final report of three Denver studies. Am Rev Respir Dis 1980; 121: 172-174.
20. Case definitions for Public Health Surveillance. Morb Mortal Wkly Rep 1990; 39 (RR-13): 1-43.
21. Chaulk C P, Moore-Rice K, Rizzo R, Chaisson R E. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995; 274: 945-951.
22. Weis S E, Slocum P C, Blais F X, et al. The effect of directly observed therapy on the rates of drug resistance and relapse of tuberculosis. N Engl J Med 1994; 330: 1179-1184.
23. Murray C J L. World tuberculosis burden. Lancet 1990; 39: 369-372.
24. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Morb Mortal Wkly Rep 1994; 43; (RR-13): 1-120.
25. Advisory Council for the Elimination of Tuberculosis. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the elimination of tuberculosis. Morb Mortal Wkly Rep 1993; 42: RR/7.
26. Annas G J. Control of tuberculosis - The law and the public's health. N Engl J Med 1993; 328; 585-588.
27. Landesman S H. Commentary: Tuberculosis in New York City - The consequences and lessons of failure. Am J Public Health 1993; 83: 766-767.
28. Valway S E, Richards S B, Kovacovich J, Greinfinger R B, Crawford J T, Dooley S W. Outbreak of multidrug-resistant tuberculosis in a New York State prison. Am J Epidemiol 1994; 140: 113-122.
29. Daley C L, Small G F, Shecter G F, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment length polymorphism. N. Engl J Med 1992; 326: 231-235.